Mr. Proehl is a Founder, President, CEO and Director of Dermata Therapeutics, LLC. Previously he was President and CEO of Santarus, from January 2002 until January 2014, where he led the sale of Santarus to Salix Pharmaceuticals for $2.6 billion in January 2014. Prior to Santarus, Mr. Proehl was with Hoechst Marion Roussel for 14 years, where he served in various capacities, including VP of Global Marketing. While at Hoechst, he was responsible for marketing products in multiple therapeutic areas, including cardiology, allergy/respiratory, immunology, and neurology. Mr. Proehl was formerly on the Board of Auspex Pharmaceuticals before its sale to Teva for $3.5 billion, and he currently serves on the Boards of Sophiris Bio, Tenax Therapeutics, Kinetek Sports and MDRejuvena. Mr. Proehl holds a BS in Education from the State University of New York at Cortland, an MA in Exercise Physiology from Wake Forest University, and an MBA from Rockhurst University.